Find a Commonwealth Resource
Nintedanib
HealthData.Gov
Updated Jul 6, 2026
About this dataset
Ofev (nintedanib) is a prescription oral capsule medication manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. It comes in 100mg and 150mg strengths and acts as a kinase inhibitor. Approved under NDA205832, it has been on the market since 2014. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Nintedanib
Access the FDA dataset for Nintedanib — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025